Navigation Links
Vion Updates Conference Call Information
Date:11/4/2008

also being conducted. Triapine(R), a potent inhibitor of a key step in DNA synthesis, is being evaluated in clinical trials sponsored by the National Cancer Institute. For additional information on Vion and its product development programs, visit the Company's Internet web site at http://www.vionpharm.com.

This news release contains forward-looking statements. Such statements are subject to certain risk factors which may cause Vion's plans to differ or results to vary from those expected, including Vion's potential inability to file a New Drug Application or obtain regulatory approval for its products, particularly laromustine (Cloretazine,VNP40101M), delays in the regulatory approval process or delays or unfavorable results of drug trials, the possibility that favorable results of earlier preclinical studies, clinical trials or interim clinical trial data are not predictive of safety and efficacy results in later or final clinical trials, the need for additional research and testing, the inability to manufacture product, the potential inability to secure external sources of funding to continue operations, the inability to access capital and funding on favorable terms, continued operating losses and the inability to continue operations as a result, and a variety of other risks set forth from time to time in Vion's filings with the Securities and Exchange Commission, including but not limited to the risks attendant to the forward-looking statements included under Item 1A, "Risk Factors" in Vion's Form 10-K for the year ended December 31, 2007 and Form 10-Q for the quarter ended June 30, 2008. In particular, there can be no assurance as to the results of any of the Vion's clinical trials, that any of these trials will continue to full accrual, or that any of these trials will not be discontinued, modified, delayed or ceased altogether. Except in special circumstances in which a duty to update arises under la
'/>"/>

SOURCE Vion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance
2. Gonzaga Online Updates Communications Masters Program To Meet the Needs of Today's Professionals
3. SpectraScience Announces Updates
4. Vista Partners Updates Coverage on MediciNova Inc. (NASDAQ: MNOV); Maintains $8.50 Price Target
5. US Preventive Services Task Force updates prostate cancer screening recommendations
6. Sunrise Updates Date and Time of Conference Call to Discuss 2007 Financial Results and Second-Quarter 2008 Preliminary Selected Financial and Operating Data
7. Jazz Pharmaceuticals Announces Development Timeline Updates
8. Carriage Services Updates Company & Investment Profile
9. KV Pharmaceutical Company Updates Timing of Fiscal 2008 Securities and Exchange Commission Filings
10. Novadaq Updates on OPTTX Data Reported at Euroretina
11. Bioniche Updates re: Mycobacterial Cell Wall Technology Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... Dallas, TX (PRWEB) August 30, 2014 ... Cell Disruptor Industry, 2009-2019 is a professional and ... Disruptor industry. The report firstly reviews the basic ... and manufacturing technology. The report then explores global ... their product specification, capacity, Production value, and market ...
(Date:8/30/2014)... Hundreds of Byetta lawsuits ( http://www.byettalawsuit.com ... forward in U.S. courts, Bernstein Liebhard LLP reports. According ... 31, 2014, Byetta and Bydureon (an extended-release version of ... that allege the drugs caused pancreatitis, pancreatic cancer and ... claims are pending in a multidistrict litigation underway in ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 Continuing to ... Dermatology is expanding with the addition of a new ... Hammond who has provided leading-edge skin care in Grand ... Dermatology. , “As a doctor, my passion is ... Through partnering with Forefront Dermatology, I’m better able to ...
(Date:8/30/2014)... 2014 In today’s world, a good night’s ... Snoring and sleep apnea (a medical problem where the airway ... bed partners of the rest they need to face their ... snores and 20 million people in the United States alone ... and treated; and of those treated, many cannot tolerate their ...
(Date:8/30/2014)... "My wife suffered neck, back and spine ... one of two inventors from Bethel, Alaska. "The whiplash ... neck area. She tried other pillows to little avail. ... in comfort and providing extra sleep." , They created ... the head, neck and back comfortably. This enables the ...
Breaking Medicine News(10 mins):Health News:Cell Disruptor Industry Global and Chinese Analysis for 2009-2019 in New Research Report at ReportsnReports.com 2Health News:Cell Disruptor Industry Global and Chinese Analysis for 2009-2019 in New Research Report at ReportsnReports.com 3Health News:Cell Disruptor Industry Global and Chinese Analysis for 2009-2019 in New Research Report at ReportsnReports.com 4Health News:Byetta Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Settlements in More than 80 Cases 2Health News:Byetta Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Settlements in More than 80 Cases 3Health News:Expanding Care at the Forefront of Dermatology 2Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3
... To Follow Along Online, WICHITA, Kan., May 22 ... top of the world -- Mount Everest -- that ... Climb another,mountain? How about climb to the highest point ... in 50 days or less., (Photo: http://www.newscom.com/cgi-bin/prnh/20080522/AQTH080LOGO ...
... The 39th gathering of the Texas Annual,Conference of the ... to help celebrate the success of the Nothing But ... and,Cote d,Ivoire (Ivory Coast). The Woodlands UMC will host ... reading and signing on May 28 at 10:45 a.m., ...
... colleagues, at Weill Medical College of Cornell University, New York, ... shed doubt on the recently proposed designation of the protein ... a term given to the small number of cells within ... give rise to a new tumor and that therefore are ...
... rates or other outcomes was found between a group ... dialysis and another group that received a more standard ... Veterans Affairs (VA) and National Institutes of Health (NIH) ... England Journal of Medicine. Acute kidney injury, also called ...
... Corporation,(Nasdaq: CRGN ) announced today the completion ... the Company sold the 5,000,000 shares of,TopoTarget common ... for the,sale of CuraGen,s ownership in belinostat. After ... "We are pleased to announce the planned, ...
... for those seeking ... ... Board (PTCB) announced today that over 300,000 pharmacy,technicians have officially ... Pharmacy Technician,Certification Examination or transfer process since the program,s inception,in ...
Cached Medicine News:Health News:Denver Schoolteacher to Climb Summits of 50 States in 50 Days 2Health News:Denver Schoolteacher to Climb Summits of 50 States in 50 Days 3Health News:Local Methodists Host West African Choir, South African Leader at Historic Conference 2Health News:More intensive dialysis does not improve outcomes among patients with acute kidney injury 2Health News:CuraGen Sells 5 Million TopoTarget Shares for Approximately $12 Million 2Health News:CuraGen Sells 5 Million TopoTarget Shares for Approximately $12 Million 3Health News:Pharmacy Technician Certification Board (PTCB) Announces Milestone: 300,000 Certified Pharmacy Technicians (CPhT) 2Health News:Pharmacy Technician Certification Board (PTCB) Announces Milestone: 300,000 Certified Pharmacy Technicians (CPhT) 3
(Date:8/29/2014)... , Aug. 29, 2014 Diseases largely ... a generation ago are returning. Measles was declared eliminated ... in 2014 as of August 15—the highest incidence in ... public health department declared whooping cough a problem of ... are getting sick and dying from these preventable diseases—in ...
(Date:8/29/2014)... Aug. 29, 2014 /PRNewswire-iReach/ -- ChemImage will present a ... and New Zealand Forensic Science Society,s 22 nd ... Adelaide, Australia .  Forensic Scientists ... advancements that hyperspectral imaging can bring to examination ... , Director of Product Development at ChemImage, will ...
(Date:8/29/2014)... , Aug. 29, 2014  In part four ... leverage a hospital pharmacy as a strategic asset, ... practice leader for Cardinal Health,s Innovation Delivery Solutions business, ... can benefit both hospitals and patients. "Every ... one part of their job in a value-based healthcare ...
Breaking Medicine Technology:Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 2Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 4
... , EXTON, Pa., Dec. 23 BioTrends ... "TreatmentTrends®: Anemia in the United States," ... approximately 400 physicians in clinical practice. The ... approaches as reported by Hematologists, Oncologists, Nephrologists, Gastroenterologists, ...
... , BEVERLY HILLS, Calif., ... abundance of media coverage and attention surrounding prescription painkillers, largely ... past 12 months, several high-profile celebrities have been linked to ... while autopsies for Michael Jackson, Anna Nicole Smith, DJ AM, ...
Cached Medicine Technology:BioTrends Publishes New Report Exploring Treatment Patterns for Anemia Across a Variety of Physician Specialties 2The Waismann Method Reflects on 2009: The Year of the Prescription Painkiller 2The Waismann Method Reflects on 2009: The Year of the Prescription Painkiller 3The Waismann Method Reflects on 2009: The Year of the Prescription Painkiller 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: